Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis and Staging of Bladder Cancer

This scientific review assesses the current diagnostic capabilities of diffusion-weighted images used in the magnetic resonance imaging protocol for bladder cancer. It actualizes this impulse sequence employed within the framework of a multiparametric MRI study as one of the functional techniques. The review deals with the possibilities of diffusion-weighted images used in an independent version and in combination with T2-weighted images to visualize a tumor, postoperative changes, and associated pathology. It gives differential diagnostic criteria in identifying the extent of tumor invasion, including that with accuracy assessment according to the measured diffusion coefficient.

The sources of the review are publications included in the peer-reviewed databases PubMed, Scopus, eLIBRARY and the open sources Google Scholar, Researchgate. 

1. Kaprin A.D., Starinskiy V.V., Petrova G.V. (Eds) Malignant neoplasms in Russia in 2016 (morbidity and mortality). Moscow; 2018 (in Russ.). Available at: http://www.oncology.ru/ service/statistics/ (accessed 14.09.2018).]

2. Mahdavifar N., Ghoncheh M., Pakzad R., Momenimovahed Z., Salehiniya H. Epidemiology, incidence and mortality of bladder cancer and their relationship with the development index in the world. Asian Pacific J. Canc. Preven.2016; 17 (1): 381–6. DOI: 10.7314/apjcp.2016.17.1.381

3. Bostrom P.J., van Rhijn B.W.G., Fleshner N., Finelli A., Jewett M., Thoms J. et al. Staging and staging errors in bladder cancer. Eur. Urol. Suppl. [Internet]. 2010; 9 (1): 2–9. DOI: 10.1016/j.eursup.2010.01.005

4. Aarsæther E., Patel H.R. Contemplating bladder cancer care: can we cut costs and improve quality of care? Exp. Rev. Antican. Ther. [Internet]. 2013; 13 (6): 639–40. DOI: 10.1586/era.13.29

5. Babjuk M., Böhle A., Burger M., Capoun O., Cohen D., Compérat E.M. et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur. Urol. [Internet]. 2017; 71 (3): 447–61. DOI: 10.1016/j.eururo. 2016.05.041

6. Alfred Witjes J., Lebret T., Compérat E.M., Cowan N.C., De Santis M., Bruins H.M. et al. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Eur. Urol. [Internet]. 2017; 71 (3): 462–75. DOI: 10.1016/ j.eururo.2016.06.020

7. Bayoumi Y., Heikal T., Darweish H. Survival benefit of adjuvant radiotherapy in stage III and IV bladder cancer: results of 170 patients. Canc. Manag. Res.2014; 459. DOI: 10.2147/ cmar.s69055

8. Tekes A., Kamel I., Imam K., Szarf G., Schoenberg M., Nasir K. et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. Am. J. Roentgenol. 2005; 184 (1): 121–7. DOI: 10.2214/ajr.184.1.01840121

9. Yoshida S. Diffusion-weighted magnetic resonance imaging in management of bladder cancer, particularly with multimodal bladder-sparing strategy. World J. Radiol. 2014; 6 (6): 344. DOI: 10.4329/wjr.v6.i6.344

10. Grigor'ev E.G., Frolova I.G., Usynin E.A., Velichko S.A., Okunev V.V., Gol'dberg A.V. Role of high-field magnetic resonance imaging in diagnosis of bladder cancer (literature review). Siberian Journal of Oncology. 2014; 3: 65–71 (in Russ.).

11. Takeuchi M., Sasaki S., Naiki T., Kawai N., Kohri K., Hara M. et al. MR imaging of urinary bladder cancer for T-staging: a review and a pictorial essay of diffusion-weighted imaging. J. Magn. Res. Imag. 2013; 38 (6): 1299–309. DOI: 10.1002/ jmri.24227

12. Takeuchi M., Sasaki S., Ito M., Okada S., Takahashi S., Kawai T. et al. Urinary bladder cancer: diffusion-weighted MR imaging – accuracy for diagnosing T stage and estimating histologic grade. Radiology. 2009; 251 (1): 112–21. DOI: 10.1148/radiol.2511080873

13. Watanabe H., Kanematsu M., Kondo H., Goshima S., Tsuge Y., Onozuka M. et al. Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value? Am. J. Roentgenol. 2009; 192 (5): 1361–6. DOI: 10.2214/ ajr.08.1430

14. El-Assmy A., Abou-El-Ghar M.E., Mosbah A., El-Nahas A.R., Refaie H.F., Hekal I.A. et al. Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging. Eur. Radiol. 2009; 19 (7): 1575–81. DOI: 10.1007/s00330-0091340-7

15. Hafeez S., Huddart R. Advances in bladder cancer imaging. BMC Medicine. 2013; 11 (1). DOI: 10.1186/1741-7015-11104

16. Wang H., Pui M.H., Guo Y., Yang D., Pan B., Zhou X. Diffusionweighted MRI in bladder carcinoma: the differentiation between tumor recurrence and benign changes after resection. Abdomin. Imag. 2013; 39 (1): 135–41. DOI: 10.1007/s00261-013-0038-0

17. Nguyen H.T., Shah Z.K., Mortazavi A., Pohar K.S., Wei L., Jia G. et al. Non-invasive quantification of tumour heterogeneity in water diffusivity to differentiate malignant from benign tissues of urinary bladder: a phase I study. Eur. Radiol. 2016; 27 (5): 2146–52. DOI: 10.1007/s00330-0164549-2

18. Narumi Y., Kadota T., Inoue E., Kuriyama K., Fujita M., Hosomi N. et al. Bladder tumors: staging with gadoliniumenhanced oblique MR imaging. Radiology. 1993; 187 (1): 145–50. DOI: 10.1148/radiology.187.1.8451401

19. Wong-You–Cheong J.J., Woodward P.J., Manning M.A., Sesterhenn I.A. Neoplasms of the urinary bladder: radiologic-pathologic correlation. RadioGraphics. 2006; 26 (2): 553–80. DOI: 10.1148/rg.262055172

20. Matsuki M., Inada Y., Tatsugami F., Tanikake M., Narabayashi I., Katsuoka Y. Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. Eur. Radiol. 2006; 17 (1): 201–4. DOI: 10.1007/s00330-006-0281-7

21. Kobayashi S., Koga F., Yoshida S., Masuda H., Ishii C., Tanaka H. et al. Diagnostic performance of diffusionweighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur. Radiol.2011; 21 (10): 2178–86. DOI: 10.1007/s00330-0112174-7

22. Abou-El-Ghar M.E., El-Assmy A., Refaie H.F., El-Diasty T. Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria. Radiology. 2009; 251 (2): 415–21. DOI: 10.1148/radiol.2503080723

23. Ceylan K., Taken K., Gec ,it I., Pirinc ,c ,i N., Giines M., Karaman M. Comparison of cystoscopy with diffusion-weighted magnetic resonance images used in the diagnosis and follow-up of patients with bladder tumor. Eur. Urol. Suppl. 2010; 9 (6): 596–7. DOI: 10.1016/s1569-9056(10) 61441-8

24. Afifi A.H., Abdel Maksoud T.A.S., EL-noueam K.I., Ataa M.A., Abdallah D.M. Multiparametric-MRI as a comprehensive study in evaluation, characterization & local staging of urinary bladder carcinomas. Egypt. J. Radiol. Nucl. Med. 2017; 48 (2): 493–507. DOI: 10.1016/j.ejrnm.2017.01.011

25. Wang H., Pui M.H., Guan J., Li S., Lin J., Pan B. et al. Comparison of early submucosal enhancement and tumor stalk in staging bladder urothelial carcinoma. Am. J. Roentgenol. 2016; 207 (4): 797–803. DOI: 10.2214/ajr.16.16283

26. Alvarez Moreno E., Jimenez de la Pen ~a M., Cano Alonso R. Role of new functional MRI techniques in the diagnosis, staging, and followup of gynecological cancer: comparison with PET-CT. Radiol. Res. Pract.2012; 2012: 1–11. DOI: 10.1155/2012/219546

27. Down C.J., Nair R., Thurairaja R. Bladder cancer. Surgery (Oxford). 2016; 34 (10): 532–9. DOI: 10.1016/j.mpsur. 2016.08.001

28. Kiss B., Thoeny H.C., Studer U.E. Current status of lymph node imaging in bladder and prostate cancer. Urology [Internet]. 2016; 96: 1–7. DOI: 10.1016/j.urology. 2016.02.014

29. Rechichi G., Galimberti S., Oriani M., Perego P., Valsecchi M.G., Sironi S. ADC maps in the prediction of pelvic lymph nodal metastatic regions in endometrial cancer. Eur. Radiol. 2012; 23 (1): 65–74. DOI: 10.1007/s00330-0122575-2

30. Beer A.J., Eiber M., Souvatzoglou M., Holzapfel K., Ganter C., Weirich G. et al. Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in 11C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer. Mol. Imag. Biol.2010; 13 (2): 352–61. DOI: 10.1007/s11307-010-0337-6

31. Papalia R., Simone G., Grasso R., Augelli R., Faiella E., Guaglianone S. et al. Diffusion-weighted magnetic resonance imaging in patients selected for radical cystectomy: detection rate of pelvic lymph node metastases. BJU Intern. 2011; 109 (7): 1031–6. DOI: 10.1111/j.1464-410x.2011. 10446.x

32. Mir N., Sohaib S., Collins D., Koh D. Fusion of high b-value diffusion-weighted and T2-weighted MR images improves identification of lymph nodes in the pelvis. J. Med. Imag. Radiat. Oncol. 2010; 54 (4): 358–64. DOI: 10.1111/j.17549485.2010.02182.x

33. Thoeny H.C., Triantafyllou M., Birkhaeuser F.D., Froehlich J.M., Tshering D.W., Binser T. et al. Combined ultrasmall superparamagnetic particles of iron oxide – enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur. Urol. 2009; 55 (4): 761–9. DOI: 10.1016/j.eururo.2008.12.034

34. Birkhäuser F.D., Studer U.E., Froehlich J.M., Triantafyllou M., Bains L.J., Petralia G. et al. Combined ultrasmall superparamagnetic particles of iron oxide – enhanced and diffusionweighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. Eur. Urol. 2013; 64 (6): 953–60. DOI: 10.1016/j.eururo.2013.07.03

35. Rosenkrantz A.B., Mussi T.C., Spieler B., Melamed J., Taneja S.S., Huang W.C. High-grade bladder cancer: association of the apparent diffusion coefficient with metastatic disease: preliminary results. J. Magn. Res. Imag.2012; 35 (6): 1478–83. DOI: 10.1002/jmri.23590

36. Kobayashi S., Koga F., Kajino K., Yoshita S., Ishii C., Tanaka H. et al. Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer. J. Magn. Res. Imag. 2013; 39 (1): 172–8. DOI: 10.1002/jmri.24148

37. Ohgiya Y., Suyama J., Sai S., Kawahara M., Takeyama N., Ohike N. et al. Preoperative T staging of urinary bladder cancer: efficacy of stalk detection and diagnostic performance of diffusion-weighted imaging at 3T. Magn. Res. Med. Sc. 2014; 13 (3): 175–81. DOI: 10.2463/mrms.2013-0104

38. Huddart R.A., Jones R., Choudhury A. A new dawn for bladder cancer? Recommendations from the National Institute for Health and Care Excellence (NICE) on Managing Bladder Cancer. Clin. Oncol. 2015; 27 (7): 380–1. DOI: 10.1016/ j.clon.2015.03.008

39. Dolgushin B.I., Tyurin I.E., Luk’yanchenko A.B., Medvedeva B.M., Dronova E.L., Shima Volfgan, Ringl Velmut. Standards for CT and MRI studies in oncology using intravenous contrast enhancement. Medical Alphabet. 2013; 3-4 (23): 29–37 (in Russ.).